9 transactions in one company, from January 8, 2026 to February 12, 2026.
Where this insider traded.
| Company | Ticker | Trades | Bought | Sold |
|---|---|---|---|---|
| Enliven Therapeutics, Inc. | ELVN | 9 | — | $4.2M |
9 in total, newest filings first.
| Company | Ticker | Insider | Date | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|---|
| Enliven Therapeutics, Inc. | ELVN | Joseph P. LyssikatosChiefDERIV | Feb 12 | A | 112,500 | $0.00 | —? |
| Enliven Therapeutics, Inc. | ELVN | Joseph P. LyssikatosChief | Feb 12 | A | 18,750 | $0.00 | — |
| Enliven Therapeutics, Inc. | ELVN | Joseph P. LyssikatosChief | Feb 6 | SPLAN | 5,000 | $29.04 | $145K |
| Enliven Therapeutics, Inc. | ELVN | Joseph P. LyssikatosChief | Jan 20 | SPLAN | 14,509 | $26.90 | $390K |
| Enliven Therapeutics, Inc. | ELVN | Joseph P. LyssikatosChief | Jan 20 | SPLAN | 5,491 | $26.37 | $145K |
| Enliven Therapeutics, Inc. | ELVN | Joseph P. LyssikatosChief | Jan 9 | SPLAN | 50,000 | $29.13 | $1.5M |
| Enliven Therapeutics, Inc. | ELVN | Joseph P. LyssikatosChief | Jan 9 | SPLAN | 41,198 | $24.90 | $1.0M |
| Enliven Therapeutics, Inc. | ELVN | Joseph P. LyssikatosChief | Jan 8 | SPLAN | 33,802 | $24.92 | $842K |
| Enliven Therapeutics, Inc. | ELVN | Joseph P. LyssikatosChief | Jan 8 | SPLAN | 7,500 | $20.13 | $151K |